Cyclodextrins Market

By Product Type;

α-Cyclodextrin, β-Cyclodextrin, γ-Cyclodextrin, and Others [Hydroxypropyl and Methylated]

By Grade;

Food Grade and Pharmaceutical Grade

By Functionality;

Encapsulation Agents and Stabilizers

By End-Use;

Food & Beverage, Pharmaceuticals, Cosmetics & Personal Care, Chemicals, Packaging, and Others [Agriculture and Biotechnology]

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2020 - 2030)
Report ID: Rn632507209 Published Date: August, 2025 Updated Date: September, 2025

Cyclodextrins Market Overview

Cyclodextrins Market (USD Million)

Cyclodextrins Market was valued at USD 183.24 million in the year 2024. The size of this market is expected to increase to USD 254.43 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.8%.


Cyclodextrins Market

*Market size in USD million

CAGR 4.8 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.8 %
Market Size (2024)USD 183.24 Million
Market Size (2031)USD 254.43 Million
Market ConcentrationHigh
Report Pages321
183.24
2024
254.43
2031

Major Players

  • Wacker Chemie AG.
  • Ligand Pharmaceuticals Incorporated
  • Roquette Freres
  • Wellona Pharma Private Limited.
  • Cambrex Corporation
  • Cyclo Therapeutics Inc
  • Cyclolab
  • Tocopharm Co. Limited
  • Midas Pharma GmbH
  • Cayman Chemical Company

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Cyclodextrins Market

Fragmented - Highly competitive market without dominant players


The Cyclodextrins Market is witnessing consistent growth, fueled by its multifunctional use in pharmaceuticals, food, cosmetics, and biotechnology. Known for forming inclusion complexes, cyclodextrins are vital for enhancing solubility and stability, with more than 55% of applications concentrated in drug formulations. Their eco-friendly and safe profile positions them as a preferred choice in innovative product development.

Pharmaceutical Sector Leading Utilization
Cyclodextrins have become indispensable in healthcare, improving drug bioavailability, stability, and minimizing adverse effects. Currently, over 45% of newly developed pharmaceutical formulations include cyclodextrins, underscoring their value in advanced healthcare. Their integration into controlled-release systems and targeted therapies highlights their contribution to more efficient and patient-friendly treatments.

Expanding Role in Food and Cosmetics
Beyond medicine, cyclodextrins are gaining traction in the food and cosmetics sectors for their ability to stabilize flavors, mask odors, and improve texture. Nearly 35% of new formulations in these industries now rely on cyclodextrins, driven by rising demand for high-quality and sustainable consumer products. Their natural, biodegradable characteristics make them well-suited to eco-conscious innovation.

Innovation Driving Market Expansion
Ongoing research and development are shaping the future of cyclodextrins, with nearly 30% of advancements focusing on modified derivatives that deliver superior performance. These innovations are unlocking applications in nanotechnology, agriculture, and environmental management, demonstrating the broad potential of cyclodextrins as versatile enablers of industrial progress.

Strong Growth Prospects
The Cyclodextrins Market is set for sustained growth as industries increasingly adopt biodegradable and functional materials. With more than 40% of new product introductions across healthcare and consumer goods utilizing cyclodextrins, the market is positioned as a cornerstone of sustainable and high-performance solutions.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Grade
    3. Market Snapshot, By Functionality
    4. Market Snapshot, By End-Use
    5. Market Snapshot, By Region
  4. Cyclodextrins Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing Applications in the Food and Beverage Industry
        2. Advancements in Drug Delivery Systems
        3. Increasing Investment in Healthcare Infrastructure
        4. High Consumption of Dietary Supplements
      2. Restraints
        1. Regulatory Challenges and Compliance Burdens
        2. Environmental Concerns and Sustainability Issues
        3. Intellectual Property Rights and Patent Constraints
        4. Fluctuations In Raw Material Prices
      3. Opportunities
        1. Growing Demand in Pharmaceuticals and Drug Delivery Systems
        2. Enhanced Use in the Cosmetic and Personal Care Sector
        3. Increasing Utilization in the Chemical and Agricultural Industries
        4. Advancements in Biotechnology and Nanotechnology Applications
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitve Rivalry
  5. Market Segmentation
    1. Cyclodextrins Market, By Product Type, 2021 - 2031 (USD Million)
      1. α-Cyclodextrin
      2. β-Cyclodextrin
      3. γ-Cyclodextrin
      4. Others
        1. Hydroxypropyl
        2. Methylated
    2. Cyclodextrins Market, By Grade, 2021 - 2031 (USD Million)
      1. Food Grade
      2. Pharmaceutical Grade
    3. Cyclodextrins Market, By Functionality, 2021 - 2031 (USD Million)

      1. Encapsulation Agents

      2. Stabilizers

    4. Cyclodextrins Market, By End-Use, 2021 - 2031 (USD Million)
      1. Food & Beverage
      2. Pharmaceuticals
      3. Cosmetics & Personal Care
      4. Chemicals
      5. Packaging
      6. Others
        1. Agriculture
        2. Biotechnology
    5. Cyclodextrins Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Wacker Chemie AG.
      2. Ligand Pharmaceuticals Incorporated
      3. Roquette Freres
      4. Wellona Pharma Private Limited.
      5. Cambrex Corporation
      6. Cyclo Therapeutics Inc
      7. Cyclolab
      8. Tocopharm Co. Limited
      9. Midas Pharma GmbH
      10. Cayman Chemical Company
  7. Analyst Views
  8. Future Outlook of the Market